Personalis, Inc.
Personalis transforms the active management of cancer through advanced genomic profiling. Their key offerings include the Personalis NeXT Platform™, enabling comprehensive analysis of tumor and immune system interactions. The company is positioned as a leader in precision oncology, focused on improving cancer treatment outcomes through personalized approaches.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Sivuston kohokohdat
🌟 Vastaavat luotettavat yritykset
Protalix BioTherapeutics, Inc.
Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with their ProCellEx® plant cell-based expression system. They focus on treating rare diseases and have already launched two enzyme replacement therapies. The company is known for its innovative ProCellEx® technology.
Immunocore Holdings plc
Immunocore Holdings plc pioneers TCR therapy, aiming to improve outcomes for patients with cancer, infectious, and autoimmune diseases. They develop transformative immunomodulating medicines using their ImmTAX technology. This technology activates the immune system to recognize and destroy diseased cells.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PacBio provides advanced DNA sequencing solutions, including Revio, Vega, and Onso systems. They are known for their HiFi long-read and SBB short-read technologies, used in research across human, plant, and microbial genomics. The company is positioned as a leading provider for precise and comprehensive genetic analysis.